| Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of … L Klotz, C O'Callaghan, K Ding, P Toren, D Dearnaley, CS Higano, ... Journal of Clinical Oncology 33 (10), 1151, 2015 | 183 | 2015 |
| Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities P Toren, A Zoubeidi International journal of oncology 45 (5), 1793-1801, 2014 | 155 | 2014 |
| Combination AZD5363 with enzalutamide significantly delays enzalutamide-resistant prostate cancer in preclinical models P Toren, S Kim, T Cordonnier, C Crafter, BR Davies, L Fazli, ME Gleave, ... European urology 67 (6), 986-990, 2015 | 107 | 2015 |
| Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate CancerPreclinical Evaluation of VT-464 in Prostate Cancer Models PJ Toren, S Kim, S Pham, A Mangalji, H Adomat, EST Guns, A Zoubeidi, ... Molecular cancer therapeutics 14 (1), 59-69, 2015 | 95 | 2015 |
| Small incidentally discovered testicular masses in infertile men—is active surveillance the new standard of care? PJ Toren, M Roberts, I Lecker, ED Grober, K Jarvi, KC Lo The Journal of urology 183 (4), 1373-1377, 2010 | 67 | 2010 |
| Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus P Toren, R Abouassaly, N Timilshina, G Kulkarni, S Alibhai, A Finelli Urology 82 (3), 572-578, 2013 | 57 | 2013 |
| Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study P Toren, D Margel, G Kulkarni, A Finelli, A Zlotta, N Fleshner bmj 346, 2013 | 55 | 2013 |
| Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care? L Klotz, P Toren Current oncology 19 (s1), 13-21, 2012 | 55 | 2012 |
| Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer PJ Toren, ME Gleave Asian journal of andrology 15 (3), 342, 2013 | 49 | 2013 |
| Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients FH Joncas, F Lucien, M Rouleau, F Morin, HS Leong, F Pouliot, Y Fradet, ... The Prostate 79 (15), 1767-1776, 2019 | 47 | 2019 |
| Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study D Santa Mina, MK Connor, SMH Alibhai, P Toren, C Guglietti, AG Matthew, ... Canadian Urological Association Journal 7 (11-12), E692, 2013 | 46 | 2013 |
| Periprostatic adipose tissue and prostate cancer progression: new insights into the tumor microenvironment P Toren, V Venkateswaran Clinical genitourinary cancer 12 (1), 21-26, 2014 | 40 | 2014 |
| Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer A Zardan, KM Nip, D Thaper, P Toren, S Vahid, E Beraldi, L Fazli, ... Oncogenesis 3 (8), e115-e115, 2014 | 35 | 2014 |
| Combined AKT and MEK pathway blockade in pre-clinical models of enzalutamide-resistant prostate cancer P Toren, S Kim, F Johnson, A Zoubeidi PLoS One 11 (4), e0152861, 2016 | 32 | 2016 |
| Sex steroids in the tumor microenvironment and prostate cancer progression C Boibessot, P Toren Endocrine-Related Cancer 25 (3), R179-R196, 2018 | 31 | 2018 |
| Comparison of epidural and intravenous patient controlled analgesia in patients undergoing radical cystectomy. P Toren, S Ladak, C Ma, S McCluskey, N Fleshner The Canadian journal of urology 16 (4), 4716-4720, 2009 | 30 | 2009 |
| PEG10 is associated with treatment-induced neuroendocrine prostate cancer S Kim, D Thaper, S Bidnur, P Toren, S Akamatsu, JL Bishop, C Colins, ... Journal of Molecular Endocrinology 63 (1), 39-49, 2019 | 24 | 2019 |
| Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies P Toren, R Razik, J Trachtenberg Canadian Urological Association Journal 4 (1), E12, 2010 | 21 | 2010 |
| The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomy P Toren, SMH Alibhai, A Matthew, M Nesbitt, R Kalnin, N Fleshner, ... Canadian Urological Association Journal 3 (6), 465, 2009 | 20 | 2009 |
| Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series M Haider, C Ladurner, R Mayr, Z Tandogdu, HM Fritsche, V Fradet, ... Urologic Oncology: Seminars and Original Investigations 37 (5), 300. e9-300. e15, 2019 | 18 | 2019 |
Amina ZoubeidiUniversity of British ColumbiaVerified email at prostatecentre.com
